Mopec Group Sold to Waud

Nothing Dead About this Deal: Mopec Group Sold to Waud

Mopec Group is a branded manufacturer and supplier of pathology
and laboratory equipment

 

Mopec’s products include autopsy tables, specialized
workstations, and body storage systems used by its customers
which include anatomic and forensic pathology labs in hospitals,
universities, and morgues.

SOURCE: Mopec Group

 

 

<https://www.blackfordcapital.com/> Blackford Capital has closed
the sale of <https://www.mopec.com/> Mopec Group, a branded
manufacturer and supplier of pathology and laboratory equipment,
to <https://www.waudcapital.com/> Waud Capital Partners.

Mopec’s products include autopsy tables, specialized workstations
(grossing stations), and body storage systems, as well as a range
of consumable products – biopsy bags, scalpels and knives, tissue
marking dyes, microscope slides, autopsy saws and blades,
personal protective equipment, cleaners, and disinfectants – used
by its customers which include anatomic and forensic pathology
labs in hospitals, universities, and morgues.

Source: Mopec Group

Mopec, led by CEO Francis Dirksmeier, was founded in 1992 and is
headquartered near Detroit in Madison Heights, Michigan.

“This is a very exciting milestone in Mopec’s history for our
customers and our entire organization,” said Mr. Dirksmeier. “The
partnership and investment from Waud Capital will strengthen our
capability set by investing in areas for innovation and growth,
ultimately driving greater value to all our constituents. We also
want to acknowledge our partners at Blackford Capital who have
helped transform our business and manufacturing processes to
support our strategic growth and expansion.”

 

Source: Mopec Group

 

Blackford acquired Mopec in June 2013. “This acquisition by Waud
Capital is a testament to the exceptional work done by everyone
at Mopec Group over the last 11 years,” said Jeff Johnson, the
chairman of Mopec and a managing director at Blackford. “We are
confident that under Waud Capital’s leadership, the company will
build on the foundation we helped create.”

 

Grand Rapids, Michigan-based Blackford Capital
<http://www.blackfordcapital.com/> invests in founder- and
family-owned, lower middle-market manufacturing, industrial, and
distribution companies. Target companies typically have revenues
of $20 million to $100 million and EBITDA of $2 million to $20
million.

“Today marks a significant milestone in the journey of Mopec
Group,” said Martin Stein, the founder and managing director of
Blackford Capital. “When Blackford initially invested in Mopec,
our investment thesis was to scale the business, drive
sustainable growth, and create lasting value for the stakeholders
and communities we serve. Under CEO Fran Dirksmeier’s leadership,
Mopec has achieved these goals and positioned itself as a
standout player in the medical equipment industry.”

 

Brad Staley, an Executive Partner at Waud Capital with more than
25 years in healthcare and technology operating roles across
specialty distribution, products, and services sectors, will
serve as the executive chairman of Mopec Group. “This investment
is part of our dedicated Medical Device & Supply Services
campaign we launched in partnership with Brad Staley,” said Kyle
Lattner, a partner with Waud Capital. “Mopec is an attractive
opportunity that falls squarely within the purview of the
campaign thesis and we couldn’t be more excited to partner with
Fran and the Mopec team.”

Chicago-based Waud Capital <http://www.waudcapital.com/> makes
investments from $75 million to $200 million in middle-market
companies that operate in the healthcare, software and technology
services. Since its founding in 1993, the firm has made more than
290 investments, including platform companies and add-on
acquisitions.